Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors during the central anxious system, conolidine modulates alternate molecular targets. A Science Improvements analyze uncovered that conolidine interacts Together with the atypical chemokine receptor ACKR3